Avantor, Inc.
NYQ: AVTRLive Quote
📈 ZcoreAI Score
Our AI model analyzes Avantor, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get AVTR Z-Score →About Avantor, Inc.
Healthcare
Medical Instruments & Supplies
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
📊 Fundamental Analysis
Avantor, Inc. demonstrates a profit margin of -8.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported -1.4% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -9.2%, which indicates that capital utilization is currently under pressure.
At a current price of $7.90, AVTR currently trades near the bottom of its 52-week range (7%), indicating potential value or weakness (Range: $7.26 - $16.17).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$5.39B
Trailing P/E
--
Forward P/E
9.28
Beta (5Y)
1.00
52W High
$16.17
52W Low
$7.26
Avg Volume
11.38M
Day High
Day Low